港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

康方生物

95.850

+0.4000.42%

成交量：1,787.93万

成交额：17.08亿

市值：860.73亿

市盈率：-145.30

高：98.900

开：96.400

低：92.100

收：95.450

数据加载中...

总览公司新闻公告

康方生物依沃西获批用于PD-L1阳性肺癌治疗

康方生物股价重挫17.04% 市值跌129.25亿港元

康方生物(09926)出现大手买入14.1万股，成交价$83.55，涉资1.178千万

阿斯达克财经

康方生物(09926.HK)低开近15% 野村降评级至“中性”

阿斯达克财经

快讯：恒指高开0.42% 科指涨0.57% 康方生物跌近15%

康方生物/正大天晴PD-1“派安普利单抗”获FDA批准上市

医药周报：康方生物PD1/VEGF双抗研发成果，点燃全球双抗热情【东吴医药朱国广团队】

国广有话说

医药生物行业跟踪周报：康方生物PD1/VEGF双抗研发成果，点燃全球双抗热情

【康方生物(09926.HK)：依达方®(依沃西，PD-1/VEGF)第二个适应症上市申请获得NMPA批准用于一线治疗PD-L1阳性NSCLC】康方生物(09926.HK)发布公告，由公司自主研发的全球首创双特异性抗体依达方®(依沃西，PD-1/VEGF)单药用于PD-L1阳性(TPS≥1%)的表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性的局部晚期或转移性非小细胞肺癌(NSCLC)的一线治疗的新药上市申请(sNDA)，已获得中国国家药品监督管理局(NMPA)批准上市。这是依沃西获批上市的第二个适应症，让中国患者“率先用上全球最优治疗方案”成为现实。

康方生物(09926.HK)：依达方®(依沃西，PD-1/VEGF)第二个适应症上市申请获得NMPA批准，用于一线治疗PD-L1阳性NSCLC

依沃西头对头试验连胜两局康方生物扭亏的希望来了？

康方生物披露HR值，Summit公司股价暴跌。

ASCO年会倒计时：港股抗癌概念股狂飙，康方生物、堃博医疗领涨创新药赛道

新华健康｜依沃西单抗NSCLC适应症获NMPA批准

经济参考网

康方生物抗体药新适应症在中国获批，美国合作方股价为何暴跌

康方生物合作伙伴Summit股价暴跌！源于总生存期数据…

PD-1/VEGF的蝴蝶效应：Summit跌36%，BioNTech跌15%，Instil Bio跌35%

康方生物再传喜讯！PD-1在美拿下两项适应症

国际金融报

第三款在美获批的国产PD-1肿瘤药来了，影响多大？

FDA批准康方生物PD-1抑制剂派安普利单抗上市

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/09926/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09926","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","market":"HK","secType":"STK","nameCN":"康方生物","latestPrice":95.85,"timestamp":1749802089038,"preClose":95.45,"halted":0,"volume":17879323,"delay":0,"floatShares":898000000,"shares":898000000,"eps":-0.659661555816345,"marketStatus":"休市中","change":0.4,"latestTime":"06-13 16:08:09","open":96.4,"high":98.9,"low":92.1,"amount":1707957471,"amplitude":0.071241,"askPrice":95.85,"askSize":16000,"bidPrice":95.4,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.659661555816345,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1750037400000},"marketStatusCode":7,"adr":0,"listingDate":1587657600000,"exchange":"SEHK","adjPreClose":95.45,"openAndCloseTimeList":[[1749778200000,1749787200000],[1749790800000,1749801600000]],"volumeRatio":1.0401857469681908,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09926\",,,,,undefined,":{"symbol":"09926","floatShares":898000000,"roa":"-4.16%","roe":"-8.89%","lyrEps":-0.659662,"volumeRatio":1.0401857469681908,"shares":898000000,"dividePrice":0,"high":98.9,"amplitude":0.071241,"preClose":95.45,"low":92.1,"week52Low":35,"pbRate":"11.58","psRate":"37.14","week52High":105.5,"institutionHeld":0,"latestPrice":95.85,"committee":-0.882353,"eps":-0.659661555816345,"divideRate":0,"volume":17879323,"delay":0,"ttmEps":-0.659661555816345,"open":96.4,"prevYearClose":60.7,"prevWeekClose":82.25,"prevMonthClose":83.8,"prevQuarterClose":76.2,"fiveDayClose":82.25,"twentyDayClose":83.5,"sixtyDayClose":72},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09926\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530549955","title":"康方生物依沃西获批用于PD-L1阳性肺癌治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2530549955","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530549955?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 09:32","pubTimestamp":1745803955,"startTime":"0","endTime":"0","summary":"4月27日，康方生物（09926）发布公告，宣布其自主研发的双特异性抗体依达方?（依沃西，PD-1/VEGF）获得中国国家药品监督管理局（NMPA）批准，用于一线治疗PD-L1阳性非小细胞肺癌（NSCLC）。这是依沃西获得的第二个适应症，标志着中国患者能够率先使用全球最优治疗方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504283390722024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0348784397.USD","BK1161","09926","LU1169590202.USD","LU1720050803.USD","PD","LU2488822045.USD","BK1574","LU0417516571.SGD","LU0348783233.USD","LU1169589451.USD","LU1794554557.SGD","BK4023","IE00BPRC5H50.USD"],"gpt_icon":0},{"id":"2530499411","title":"康方生物股价重挫17.04% 市值跌129.25亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530499411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530499411?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 09:30","pubTimestamp":1745803806,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘09时30分，康方生物股票出现异动，股价急速下挫17.04%。截至发稿，该股报82.050港元/股，成交量171.604万股，换手率0.19%，振幅3.49%。资金方面，该股资金流入2690.3万港元，流出1296.66万港元。机构评级方面，在所有24家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。康方生物股票所在的生物技术行业中，整体跌幅为2.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093007a469be3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093007a469be3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348784397.USD","LU0348783233.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","LU0417516571.SGD","IE00B5MMRT66.SGD","LU1794554557.SGD","09926","BK1574","LU1720050803.USD"],"gpt_icon":1},{"id":"2530499337","title":"康方生物(09926)出现大手买入14.1万股，成交价$83.55，涉资1.178千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2530499337","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530499337?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 09:30","pubTimestamp":1745803800,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在上午09:30出现大手买入，成交量为14.1万，成交价为港币$83.55，涉资1.178千万。至目前为止，股价跌17.037%，今日最高价为$84.1，而最低价为$82.0，总成交量为140.404万股，总成交金额港币$1.18亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT25042855/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1794554557.SGD","IE00BPRC5H50.USD","LU0348784397.USD","BK1161","LU1720050803.USD","LU0348783233.USD","IE00B5MMRT66.SGD","BK1574","LU0417516571.SGD","LU2488822045.USD","09926","IE00B543WZ88.USD"],"gpt_icon":0},{"id":"2530061499","title":"康方生物(09926.HK)低开近15%  野村降评级至“中性”","url":"https://stock-news.laohu8.com/highlight/detail?id=2530061499","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530061499?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 09:28","pubTimestamp":1745803680,"startTime":"0","endTime":"0","summary":"康方生物今日低开14.96%，最低见84.1元。现报84.1元，跌14.96%，成交125.4万股，涉资1.05亿元。这是依沃西获批上市的第二个适应症，让中国患者“率先用上全球最优治疗方案”成为现实。在ITT人群中，在39%成熟度时进行的总生存期的期中分析结果显示，依沃西对比帕博利珠单抗具有显著的临床生存获益，HR=0.777，降低死亡风险22.3%。股价在2025年4月上涨50%，因此部分投资者可能会选择在此消息后获利了结。因此，该行将其评级下调至“中性”，目标价上调至99.66元。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200914151046636_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200914151046636_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1436218/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09926"],"gpt_icon":1},{"id":"2530026495","title":"快讯：恒指高开0.42% 科指涨0.57% 康方生物跌近15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530026495","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530026495?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 09:20","pubTimestamp":1745803200,"startTime":"0","endTime":"0","summary":"　　4月28日消息，美股上周五先跌后反弹，大市早段受消费信心数据疲弱影响，道指一度跌幅超过300点，其后低位反弹，三大指数均录得升幅收市。美元走势向好，美国十年期债息回落至4.25厘水平，金价继续回吐，油价走势靠稳。　　今日港股三大指数集体高开，恒生指数涨0.42%，报22072.35点，恒生科指涨0.57%，国企指数涨0.40%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-28/doc-ineusnve2254591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0348783233.USD","IE00B543WZ88.USD","HSTECH","HHImain","513600","09926","HSI","IE00B5MMRT66.SGD","LU1794554557.SGD","YANG","LU2488822045.USD","MHImain","HSImain","BK1161","LU1720050803.USD","LU0348784397.USD","02833","IE00BPRC5H50.USD","LU0417516571.SGD","BK4614","MCHmain","BK1574"],"gpt_icon":0},{"id":"2530609284","title":"康方生物/正大天晴PD-1“派安普利单抗”获FDA批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2530609284","media":"药渡","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530609284?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 07:31","pubTimestamp":1745796709,"startTime":"0","endTime":"0","summary":"此前，派安普利单抗已在中国获批上市，用于晚期鼻咽癌一线和二线后线治疗。派安普利单抗的获批为这些患者带来了新的希望。目前，全球范围内针对鼻咽癌的PD-1/PD-L1单抗药物市场尚处于发展阶段，派安普利单抗的获批有望迅速占领市场份额。派安普利单抗的美国获批上市为康方生物的国际化战略奠定了坚实基础。阿斯利康长效C5补体抑制剂“瑞利珠单抗”获批上市","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428082537a469af5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428082537a469af5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1720050803.USD","09926","IE00B543WZ88.USD","LU0348784397.USD","BK1574","LU1794554557.SGD","LU0348783233.USD","LU0417516571.SGD","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","IE00B5MMRT66.SGD"],"gpt_icon":1},{"id":"2530528584","title":"医药周报：康方生物PD1/VEGF双抗研发成果，点燃全球双抗热情【东吴医药朱国广团队】","url":"https://stock-news.laohu8.com/highlight/detail?id=2530528584","media":"国广有话说","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530528584?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 23:47","pubTimestamp":1745768855,"startTime":"0","endTime":"0","summary":"PD-1/VEGF双抗确定性进一步增强，关注IO双抗赛道投资机会。4月25日，康方生物依沃西单抗注射液新适应症获NMPA批准上市，单药用于PD-L1阳性的EGFR阴性和ALKzc的局部晚期或转移性非小细胞肺癌的一线治疗。ASCO大会第二代双抗IO集体披露数据，板块将迎来强数据催化。今年ASCO会议康方生物、三生制药、华博生物将披露PD-1/VEGF双抗数据，此外信达、泽璟也将披露各自的第2代IO数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428010826a469624c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428010826a469624c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348783233.USD","09939","IE00B543WZ88.USD","LU0348784397.USD","LU1794554557.SGD","LU2488822045.USD","LU1720050803.USD","BK1515","BK1161","IE00B5MMRT66.SGD","BK1574","IE00BPRC5H50.USD","09926","LU0417516571.SGD"],"gpt_icon":1},{"id":"2530455487","title":"医药生物行业跟踪周报：康方生物PD1/VEGF双抗研发成果，点燃全球双抗热情","url":"https://stock-news.laohu8.com/highlight/detail?id=2530455487","media":"东吴证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530455487?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 22:07","pubTimestamp":1745762843,"startTime":"0","endTime":"0","summary":"PD-1/VEGF双抗确定性进一步增强，关注IO双抗赛道投资机会。依沃西成功带动PD-1/VEGF双抗赛道全球关注度大幅提升，该赛道相关产品均有望收益，包括普米斯PDL1/VEGF双抗处于III期临床；三生制药PD1/VEGF双抗II期阶段数据疗效优异，III期临床准备中，并于近期获得国内突破性疗法认定；宜明昂科、荣昌生物、华海药业、神州细胞等PD1/VEGF双抗处于II期临床阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042722074397475db6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042722074397475db6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0417516571.SGD","IE00BPRC5H50.USD","LU1720050803.USD","LU0348784397.USD","LU1794554557.SGD","LU2488822045.USD","09926","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1574","LU0348783233.USD"],"gpt_icon":1},{"id":"2530343711","title":"【康方生物(09926.HK)：依达方®(依沃西，PD-1/VEGF)第二个适应症上市申请获得NMPA批准 用于一线治疗PD-L1阳性NSCLC】康方生物(09926.HK)发布公告，由公司自主研发的全球首创双特异性抗体依达方®(依沃西，PD-1/VEGF)单药用于PD-L1阳性(TPS≥1%)的表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性的局部晚期或转移性非小细胞肺癌(NSCLC)的一线治疗的新药上市申请(sNDA)，已获得中国国家药品监督管理局(NMPA)批准上市。这是依沃西获批上市的第二个适应症，让中国患者“率先用上全球最优治疗方案”成为现实。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530343711","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530343711?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 20:01","pubTimestamp":1745755264,"startTime":"0","endTime":"0","summary":"康方生物(09926.HK)发布公告，由公司自主研发的全球首创双特异性抗体依达方®(依沃西，PD-1/VEGF)单药用于PD-L1阳性(TPS≥1%)的表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性的局部晚期或转移性非小细胞肺癌(NSCLC)的一线治疗的新药上市申请(sNDA)，已获得中国国家药品监督管理局(NMPA)批准上市。这是依沃西获批上市的第二个适应症，让中国患者“率先用上全球最优治疗方案”成为现实。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/27200149930796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00B543WZ88.USD","IE00B5MMRT66.SGD","PD","LU1794554557.SGD","LU1169589451.USD","BK1161","LU1720050803.USD","IE00BPRC5H50.USD","BK1574","BK4008","BK4500","LU1169590202.USD","LU0348784397.USD","BK4588","09926","ALK","BK4585","LU2488822045.USD","LU0348783233.USD","BK4023","LU0417516571.SGD"],"gpt_icon":0},{"id":"2530379034","title":"康方生物(09926.HK)：依达方®(依沃西，PD-1/VEGF)第二个适应症上市申请获得NMPA批准，用于一线治疗PD-L1阳性NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2530379034","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530379034?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 19:58","pubTimestamp":1745755137,"startTime":"0","endTime":"0","summary":"格隆汇4月27日丨康方生物宣布，由公司自主研发的全球首创双特异性抗体依达方单药用于PD-L1阳性的表皮生长因子受体基因突变阴性和间变性淋巴瘤激酶阴性的局部晚期或转移性非小细胞肺癌的一线治疗的新药上市申请，已获得中国国家药品监督管理局批准上市。这是依沃西获批上市的第二个适应症，让中国患者‘‘率先用上全球最优治疗方案’’成为现实。依沃西是全球首个在头对头帕博利珠单抗的III期临床研究中获得显著阳性结果的药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/27195849930778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1794554557.SGD","IE00BPRC5H50.USD","LU0348783233.USD","IE00B5MMRT66.SGD","LU1720050803.USD","PD","BK1574","LU0348784397.USD","LU0417516571.SGD","LU1169589451.USD","BK1161","LU1169590202.USD","IE00B543WZ88.USD","LU2488822045.USD","BK4023","09926"],"gpt_icon":1},{"id":"2530101336","title":"依沃西头对头试验连胜两局 康方生物扭亏的希望来了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2530101336","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530101336?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 10:07","pubTimestamp":1745719624,"startTime":"0","endTime":"0","summary":"【依沃西头对头试验连胜两局 康方生物扭亏的希望来了？】康方生物旗下明星药物依沃西单抗又在头对头试验中胜出了。4月23日，港股上市公司康方生物发布公告，双抗药物依沃西单抗（PD-1/VEGF双抗）联合化疗对比替雷利珠单抗联合化疗一线治疗晚期鳞状非小细胞肺癌（sq-NSCLC）的Ⅲ期头对头临床试验，显示强阳性结果。依沃西单抗此前还曾在与帕博利珠单抗（Keytruda，俗称K药）对比治疗局部晚期或转移性非小细胞肺癌的注册性Ⅲ期临床试验研究数据中展现出更高的客观缓解率和疾病控制率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504273389841174.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504273389841174.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","IE00B543WZ88.USD","09926","LU1720050803.USD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0417516571.SGD","LU0348784397.USD","IE00B5MMRT66.SGD","BK1161","LU0348783233.USD","LU2488822045.USD"],"gpt_icon":1},{"id":"2530109043","title":"康方生物披露HR值，Summit公司股价暴跌。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530109043","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530109043?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 09:00","pubTimestamp":1745715648,"startTime":"0","endTime":"0","summary":"康方生物披露的依沃西临床数据中，总生存期风险比为0.777，该结果引发了其美国合作伙伴Summit Therapeutics股价暴跌超36%。Summit的单一管线依赖性使其股价波动性显著，而康方生物则因中国市场快速落地占据先机。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427100216a6c9dc7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427100216a6c9dc7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0348784397.USD","BK1161","09926","LU1720050803.USD","LU2488822045.USD","BK1574","LU0417516571.SGD","LU0348783233.USD","LU1794554557.SGD","IE00BPRC5H50.USD"],"gpt_icon":1},{"id":"2530210805","title":"ASCO年会倒计时：港股抗癌概念股狂飙，康方生物、堃博医疗领涨创新药赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2530210805","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530210805?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 07:56","pubTimestamp":1745711764,"startTime":"0","endTime":"0","summary":"尽管距离年会正式开幕尚有月余，港股市场的抗癌概念股已提前进入“狂飙模式”，康方生物、堃博医疗等企业股价接连创下历史新高，而荣昌生物、信达生物、亚盛医药等一众创新药企亦紧随其后，形成“多点开花”的上涨格局。股价暴涨的导火索，是堃博医疗在肺癌治疗领域的重大突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042707573194e4299f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042707573194e4299f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","BK1161","BK1574","HSCEI","HSTECH","IE00BPRC5H50.USD","LU0417516571.SGD","02216","BK1100","LU0348783233.USD","LU1720050803.USD","IE00B5MMRT66.SGD","06978","LU2488822045.USD","IE00B543WZ88.USD","LU1794554557.SGD","LU0348784397.USD"],"gpt_icon":1},{"id":"2530812104","title":"新华健康｜依沃西单抗NSCLC适应症获NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2530812104","media":"经济参考网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530812104?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 22:08","pubTimestamp":1745676511,"startTime":"0","endTime":"0","summary":"4月25日，康方生物宣布，公司独立自主研发的全球首创PD-1/VEGF双特异性抗体新药依达方（通用名：依沃西单抗注射液）单药，用于PD-L1阳性（TPS≥1%）的表皮生长因子受体（EGFR）基因突变阴性和间变性淋巴瘤激酶（ALK）阴性的局部晚期或转移性非小细胞肺癌（NSCLC）的一线治疗的新药上市申请（sNDA），已获得中国国家药品监督管理局（NMPA）批准上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504263389731988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0070302665.USD","IE0002141913.USD","LU1989772840.SGD","SG9999014542.SGD","LU0320765489.SGD","LU1066051811.HKD","LU0265550946.USD","LU1941712348.USD","ALK","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU0238689110.USD","SG9999015358.SGD","LU2112291526.USD","LU2361045086.USD","MRK","SG9999014559.SGD","SG9999001440.SGD","BK1574","LU0417516571.SGD","BK4007","LU1023059063.AUD","BK4559","IE00BJT1NW94.SGD","LU1585245621.USD","BK4585","LU2361044865.SGD","LU0965509283.SGD","LU1941712264.USD","LU2023250843.SGD","BK4550","SG9999013999.USD","LU0965509010.AUD","BK4500","IE00B5MMRT66.SGD","SG9999015341.SGD","SG9999001176.USD","LU1699723380.USD","LU2461242641.AUD","SGXZ57979304.SGD","LU1069347547.HKD","LU1116320737.USD","LU2023250504.SGD","BK4588","LU1057294990.SGD","09926","LU2488822045.USD","SG9999014567.USD","IE00B543WZ88.USD","LU0203345920.USD"],"gpt_icon":0},{"id":"2530014421","title":"康方生物抗体药新适应症在中国获批，美国合作方股价为何暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2530014421","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530014421?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 17:02","pubTimestamp":1745658120,"startTime":"0","endTime":"0","summary":"国家药品监督管理局官网显示，康方生物全球首创双特异性抗体新药依沃西新适应症获批上市，单药用于PD-L1表达阳性的局部晚期或转移性非小细胞肺癌的一线治疗。然而，在依沃西新适应症获批的同时，康方生物的美国合作方Summit Therapeutics公司周五股价暴跌超过36%。花旗分析师发表的最新报告观点指出，依沃西新适应症将在未来几日内在中国可用，但并不会包含OS曲线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426170345a467e037&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426170345a467e037&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348784397.USD","LU0348783233.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","LU0417516571.SGD","IE00B5MMRT66.SGD","LU1794554557.SGD","09926","BK1574","LU1720050803.USD"],"gpt_icon":0},{"id":"2530183110","title":"康方生物合作伙伴Summit股价暴跌！源于总生存期数据…","url":"https://stock-news.laohu8.com/highlight/detail?id=2530183110","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530183110?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 12:45","pubTimestamp":1745642700,"startTime":"0","endTime":"0","summary":"转自：一度医药2025年4月25日，康方生物与合作伙伴Summit Therapeutics的关键临床试验结果在肿瘤药领域引发了一场风波。康方生物首次披露了其PD-1/VEGF双特异性抗体ivonescimab与默沙东Keytruda头对头对比试验的总生存期数据，而这一结果令Summit的投资者大失所望，消息公布后，Summit纳斯达克股价暴跌近37%，直至交易暂停。该分析基于39%预设死亡事件时的数据得出。接受康方生物药物治疗的患者中位PFS为11.14个月，而Keytruda组为5.82个月，显示出显著的早期获益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042612513794e35635&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042612513794e35635&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BPRC5H50.USD","IE00B5MMRT66.SGD","BK1574","BK1161","LU1720050803.USD","LU2488822045.USD","IE00B543WZ88.USD","LU0348783233.USD","LU0348784397.USD","LU1794554557.SGD","09926","LU0417516571.SGD"],"gpt_icon":0},{"id":"2530116465","title":"PD-1/VEGF的蝴蝶效应：Summit跌36%，BioNTech跌15%，Instil Bio跌35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530116465","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530116465?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 09:18","pubTimestamp":1745630280,"startTime":"0","endTime":"0","summary":"康方生物PD-1/VEGF双抗新适应症获批，用于NSCLC一线治疗，资本市场大幅波动。尽管OS期中分析未达到统计学显著，但结果积极，行业对PD-1/VEGF关注度持续提高，预计后市将稳定上行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504261007339745c68a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504261007339745c68a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1720050803.USD","09926","IE00B543WZ88.USD","TIL","LU0348784397.USD","BK1574","LU1794554557.SGD","LU0348783233.USD","LU0417516571.SGD","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2530131277","title":"康方生物再传喜讯！PD-1在美拿下两项适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2530131277","media":"国际金融报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530131277?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 21:22","pubTimestamp":1745587344,"startTime":"0","endTime":"0","summary":"4月25日盘前，港股上市公司康方生物宣布，其PD-1单抗派安普利获美国食品药品监督管理局批准两项适应征，用于治疗晚期鼻咽癌。同时，康方生物的双抗也在4月23日披露了最新头对头临床试验结果，战胜了百济神州的替雷利珠单抗联合疗法。受上述消息影响，康方生物接连大涨。4月23日，康方生物再度披露了依沃西单抗的最新临床试验数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042521223894e2879e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042521223894e2879e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1794554557.SGD","LU0348784397.USD","BK1574","BK1161","LU0348783233.USD","IE00BPRC5H50.USD","LU0417516571.SGD","LU2488822045.USD","09926","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU1720050803.USD"],"gpt_icon":1},{"id":"2530367061","title":"第三款在美获批的国产PD-1肿瘤药来了，影响多大？","url":"https://stock-news.laohu8.com/highlight/detail?id=2530367061","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530367061?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 21:03","pubTimestamp":1745586229,"startTime":"0","endTime":"0","summary":"继君实生物、百济神州之后，第三款在美国获批的国产PD-1肿瘤药花落康方生物。在派安普利单抗注射液之前，国内已经有两款国产PD-1肿瘤药在美国获批。其中，君实生物的特瑞普利单抗于2023年10月获得FDA批准上市，并于2024年1月正式投入美国市场进行销售，是第一款成功出海美国的国产PD-1肿瘤药。文章来源：澎湃新闻第三款在美获批的国产PD-1肿瘤药来了，影响多大？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213030a466e2fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213030a466e2fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1588","BK1500","LU0348783233.USD","LU2328871848.SGD","LU1720050803.USD","BK1583","06160","BK1161","01877","IE00BPRC5H50.USD","LU0588546209.SGD","LU0417516571.SGD","BK1515","LU1794554557.SGD","IE00B5MMRT66.SGD","09926","LU0307460666.USD","BK1574","LU2488822045.USD","LU0348784397.USD","IE00B543WZ88.USD"],"gpt_icon":1},{"id":"2530156847","title":"FDA批准康方生物PD-1抑制剂派安普利单抗上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2530156847","media":"医药地理","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530156847?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 17:27","pubTimestamp":1745573230,"startTime":"0","endTime":"0","summary":"4月23日，美国FDA已批准康方生物的抗PD-1单抗派安普利单抗上市，联合顺铂或卡铂以及吉西他滨，用于复发或转移性非角化型鼻咽癌成人患者的一线治疗。此外，FDA还批准了派安普利单抗单药用于接受含铂化疗及至少一种其他治疗方案后出现疾病进展的转移性非角化型鼻咽癌成人患者。派安普利单抗康方生物与正大天晴合作开发并商业化，其是采用IgG1亚型并进行Fc段改造的新型PD-1单抗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425231733a466f874&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425231733a466f874&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU1720050803.USD","09926","BK1161","LU0417516571.SGD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU0348783233.USD","LU0348784397.USD","LU1794554557.SGD","LU2488822045.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09926\",params:#limit:5,,,undefined,":[{"date":"2025-03-30","symbol":"09926","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743298200000,"name":null,"time":"盘后","dateTimestamp":1743264000000,"actualEps":null},{"date":"2024-08-28","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null},{"date":"2024-03-18","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1710725400000,"name":null,"time":"","dateTimestamp":1710691200000,"actualEps":null},{"date":"2023-08-29","symbol":"09926","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693272600000,"name":null,"time":"","dateTimestamp":1693238400000,"actualEps":null},{"market":"HK","date":"2023-04-27","symbol":"09926","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1682524800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09926\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09926\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.55,"hold":0.05,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.55,"analysts":20,"updateTime":1745856000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09926\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09926","date":"2025-06-13","current":-152.810216,"percent":0.002473,"low":-163.883348,"twenty":-59.540166,"median":-23.982021,"eighty":13.592632,"high":20.221708,"avg":-28.150986,"sd":35.803507,"marketCap":86032580619},"quantilePoints":[{"date":"2020-06-19","current":-68.299799,"twenty":-60.537832,"median":-56.858534,"eighty":-51.676962,"marketCap":25107123914},{"date":"2020-06-26","current":-80.148198,"twenty":-63.334108,"median":-58.348972,"eighty":-52.779632,"marketCap":29435938382},{"date":"2020-07-03","current":-77.885169,"twenty":-66.643902,"median":-58.880358,"eighty":-53.202931,"marketCap":28648881206},{"date":"2020-07-10","current":-76.725563,"twenty":-70.305822,"median":-59.096072,"eighty":-53.649064,"marketCap":28491469771},{"date":"2020-07-17","current":-70.467076,"twenty":-73.692098,"median":-59.898011,"eighty":-54.044506,"marketCap":26209003960},{"date":"2020-07-24","current":-65.539086,"twenty":-72.620808,"median":-60.537717,"eighty":-54.320018,"marketCap":24280713879},{"date":"2020-07-31","current":-65.051015,"twenty":-71.63744,"median":-61.425183,"eighty":-54.696299,"marketCap":24241361020},{"date":"2020-08-07","current":-61.60528,"twenty":-71.199223,"median":-62.665648,"eighty":-55.108469,"marketCap":22982069539},{"date":"2020-08-14","current":-60.398898,"twenty":-70.692859,"median":-61.425183,"eighty":-55.354665,"marketCap":22588540951},{"date":"2020-08-21","current":-65.573062,"twenty":-70.162934,"median":-62.07047,"eighty":-55.490937,"marketCap":24634889608},{"date":"2020-08-28","current":-62.258841,"twenty":-69.624858,"median":-61.507641,"eighty":-55.875802,"marketCap":23572362421},{"date":"2020-09-04","current":-56.454938,"twenty":-69.299363,"median":-61.279481,"eighty":-56.312276,"marketCap":21447308046},{"date":"2020-09-11","current":-59.39532,"twenty":-69.034548,"median":-61.149297,"eighty":-56.381895,"marketCap":22588540951},{"date":"2020-09-18","current":-23.213534,"twenty":-68.783672,"median":-61.157004,"eighty":-56.381895,"marketCap":23847832432},{"date":"2020-09-25","current":-20.580693,"twenty":-68.608413,"median":-60.769842,"eighty":-55.354665,"marketCap":20975073740},{"date":"2020-09-30","current":-21.520592,"twenty":-68.49576,"median":-60.537717,"eighty":-54.51941,"marketCap":22037600928},{"date":"2020-10-09","current":-20.533232,"twenty":-68.261016,"median":-60.351714,"eighty":-53.10451,"marketCap":21329249469},{"date":"2020-10-16","current":-20.579561,"twenty":-67.599319,"median":-60.014098,"eighty":-50.561624,"marketCap":21368602328},{"date":"2020-10-23","current":-18.390768,"twenty":-65.566444,"median":-59.898011,"eighty":-36.752532,"marketCap":19125489376},{"date":"2020-10-30","current":-18.387929,"twenty":-65.53997,"median":-59.39532,"eighty":-22.333682,"marketCap":19125489376},{"date":"2020-11-06","current":-18.960772,"twenty":-65.539086,"median":-59.096072,"eighty":-21.714319,"marketCap":19951899411},{"date":"2020-11-13","current":-17.861227,"twenty":-65.495719,"median":-58.967855,"eighty":-21.20377,"marketCap":18810666506},{"date":"2020-11-20","current":-18.195519,"twenty":-65.439452,"median":-58.396831,"eighty":-20.827083,"marketCap":19282900812},{"date":"2020-11-27","current":-18.163703,"twenty":-65.051015,"median":-57.55027,"eighty":-20.533232,"marketCap":19204195094},{"date":"2020-12-04","current":-19.807773,"twenty":-64.515903,"median":-57.279422,"eighty":-20.022532,"marketCap":21093132316},{"date":"2020-12-11","current":-21.33702,"twenty":-64.452305,"median":-56.818854,"eighty":-20.137955,"marketCap":22667246668},{"date":"2020-12-18","current":-24.630996,"twenty":-64.186949,"median":-56.363634,"eighty":-20.421683,"marketCap":26209003960},{"date":"2020-12-24","current":-26.970119,"twenty":-63.818518,"median":-55.820181,"eighty":-20.432553,"marketCap":28727586924},{"date":"2020-12-31","current":-28.06698,"twenty":-63.629518,"median":-55.339775,"eighty":-20.494047,"marketCap":29908172688},{"date":"2021-01-08","current":-32.570823,"twenty":-63.597221,"median":-55.265323,"eighty":-20.51364,"marketCap":34984691473},{"date":"2021-01-15","current":-37.631162,"twenty":-63.40952,"median":-54.292281,"eighty":-20.570295,"marketCap":40403477353},{"date":"2021-01-22","current":-41.643907,"twenty":-63.295257,"median":-53.301351,"eighty":-20.580467,"marketCap":44693027527},{"date":"2021-01-29","current":-40.849406,"twenty":-63.217929,"median":-51.221035,"eighty":-20.705895,"marketCap":44202793221},{"date":"2021-02-05","current":-42.462881,"twenty":-63.20331,"median":-50.765107,"eighty":-20.737196,"marketCap":45673496138},{"date":"2021-02-11","current":-44.298428,"twenty":-63.199738,"median":-50.518886,"eighty":-20.809106,"marketCap":47716139078},{"date":"2021-02-19","current":-44.620302,"twenty":-63.148699,"median":-50.046102,"eighty":-20.827888,"marketCap":48083814807},{"date":"2021-02-26","current":-38.677591,"twenty":-62.923489,"median":-46.003712,"eighty":-21.003278,"marketCap":41588210258},{"date":"2021-03-05","current":-36.070462,"twenty":-62.63965,"median":-44.620302,"eighty":-21.129156,"marketCap":38687657283},{"date":"2021-03-12","current":-33.577269,"twenty":-62.438134,"median":-44.247826,"eighty":-21.158012,"marketCap":35950515744},{"date":"2021-03-19","current":-35.993074,"twenty":-62.327407,"median":-43.908841,"eighty":-21.185375,"marketCap":38524245848},{"date":"2021-03-26","current":-37.072786,"twenty":-62.202297,"median":-42.138278,"eighty":-21.221991,"marketCap":39504714459},{"date":"2021-04-01","current":-41.283195,"twenty":-62.015041,"median":-41.751169,"eighty":-21.266862,"marketCap":43875970351},{"date":"2021-04-09","current":-31.196593,"twenty":-61.70772,"median":-41.695813,"eighty":-21.319481,"marketCap":43590000339},{"date":"2021-04-16","current":-30.642009,"twenty":-61.527169,"median":-40.849406,"eighty":-21.393706,"marketCap":42977207457},{"date":"2021-04-23","current":-31.96013,"twenty":-61.441675,"median":-40.344151,"eighty":-21.433299,"marketCap":44938144680},{"date":"2021-04-30","current":-30.816187,"twenty":-61.312504,"median":-39.558199,"eighty":-21.441654,"marketCap":43508294622},{"date":"2021-05-07","current":-28.864106,"twenty":-61.27851,"median":-38.69692,"eighty":-21.489217,"marketCap":41016270235},{"date":"2021-05-14","current":-29.343194,"twenty":-61.208677,"median":-38.024901,"eighty":-21.636828,"marketCap":41669915976},{"date":"2021-05-21","current":-32.815059,"twenty":-61.158545,"median":-37.656345,"eighty":-21.839766,"marketCap":46613111890},{"date":"2021-05-28","current":-34.118192,"twenty":-61.102433,"median":-37.609185,"eighty":-22.049324,"marketCap":48941724842},{"date":"2021-06-04","current":-35.625611,"twenty":-60.979677,"median":-37.553441,"eighty":-22.116923,"marketCap":50861809206},{"date":"2021-06-10","current":-37.08623,"twenty":-60.769842,"median":-37.072786,"eighty":-22.258985,"marketCap":52986157863},{"date":"2021-06-18","current":-35.659842,"twenty":-60.584234,"median":-36.485136,"eighty":-22.270088,"marketCap":50494133476},{"date":"2021-06-25","current":-36.773665,"twenty":-60.537647,"median":-36.47778,"eighty":-22.279086,"marketCap":51923983534},{"date":"2021-06-30","current":-36.160141,"twenty":-60.48212,"median":-36.485136,"eighty":-22.301737,"marketCap":51188632076},{"date":"2021-07-09","current":-33.001535,"twenty":-60.380024,"median":-36.358401,"eighty":-22.333501,"marketCap":46572259032},{"date":"2021-07-16","current":-33.61015,"twenty":-60.247205,"median":-36.160141,"eighty":-22.684742,"marketCap":47430169066},{"date":"2021-07-23","current":-30.660269,"twenty":-60.081955,"median":-36.081197,"eighty":-23.212212,"marketCap":43263177469},{"date":"2021-07-30","current":-29.749657,"twenty":-60.025123,"median":-35.993074,"eighty":-23.780519,"marketCap":42119297422},{"date":"2021-08-06","current":-26.92917,"twenty":-59.948494,"median":-35.665203,"eighty":-24.743522,"marketCap":38034011542},{"date":"2021-08-13","current":-25.592675,"twenty":-59.918873,"median":-35.597545,"eighty":-24.965673,"marketCap":36195632896},{"date":"2021-08-20","current":-20.885732,"twenty":-59.826938,"median":-35.459665,"eighty":-24.434422,"marketCap":29454911194},{"date":"2021-08-27","current":-21.082492,"twenty":-59.613719,"median":-35.394103,"eighty":-23.176546,"marketCap":29863439782},{"date":"2021-09-03","current":-31.115126,"twenty":-59.45425,"median":-35.211108,"eighty":-23.023412,"marketCap":34806635697},{"date":"2021-09-10","current":-32.055246,"twenty":-59.359698,"median":-34.971061,"eighty":-23.122707,"marketCap":35950515744},{"date":"2021-09-17","current":-31.163903,"twenty":-59.210176,"median":-34.572405,"eighty":-23.198629,"marketCap":34847488556},{"date":"2021-09-24","current":-31.295563,"twenty":-59.102123,"median":-34.437371,"eighty":-23.212212,"marketCap":35010899991},{"date":"2021-09-30","current":-31.154784,"twenty":-59.047908,"median":-34.407249,"eighty":-23.447883,"marketCap":34970047132},{"date":"2021-10-08","current":-29.845898,"twenty":-58.976264,"median":-34.085183,"eighty":-24.385279,"marketCap":33499344216},{"date":"2021-10-15","current":-32.807984,"twenty":-58.969537,"median":-33.89682,"eighty":-24.581853,"marketCap":36849278637},{"date":"2021-10-22","current":-33.585285,"twenty":-58.897857,"median":-33.786096,"eighty":-24.856047,"marketCap":37993158684},{"date":"2021-10-29","current":-31.568779,"twenty":-58.531823,"median":-33.627637,"eighty":-25.019036,"marketCap":35623692873},{"date":"2021-11-05","current":-28.336247,"twenty":-58.387259,"median":-33.581277,"eighty":-25.13981,"marketCap":32028641299},{"date":"2021-11-12","current":-31.135474,"twenty":-58.165915,"median":-33.566565,"eighty":-25.305935,"marketCap":35337722862},{"date":"2021-11-19","current":-36.658551,"twenty":-57.747713,"median":-33.576384,"eighty":-25.505551,"marketCap":41547357399},{"date":"2021-11-26","current":-34.737009,"twenty":-57.465203,"median":-33.61015,"eighty":-25.671516,"marketCap":39382155883},{"date":"2021-12-03","current":-31.939354,"twenty":-57.376977,"median":-33.627637,"eighty":-26.141756,"marketCap":36277338614},{"date":"2021-12-10","current":-30.771813,"twenty":-57.264113,"median":-33.577269,"eighty":-26.43668,"marketCap":35010899991},{"date":"2021-12-17","current":-26.05017,"twenty":-56.996271,"median":-33.456271,"eighty":-26.43668,"marketCap":29618322630},{"date":"2021-12-24","current":-24.338156,"twenty":-56.834726,"median":-33.106388,"eighty":-25.505551,"marketCap":27698238266},{"date":"2021-12-31","current":-24.356969,"twenty":-56.799582,"median":-33.044261,"eighty":-25.17902,"marketCap":27779943984},{"date":"2022-01-07","current":-20.242995,"twenty":-23.086945,"median":-21.779811,"eighty":-19.899701,"marketCap":23000159504},{"date":"2022-01-14","current":-20.701287,"twenty":-22.600464,"median":-21.033383,"eighty":-20.391327,"marketCap":23572099527},{"date":"2022-01-21","current":-18.577865,"twenty":-21.986595,"median":-20.680988,"eighty":-19.350843,"marketCap":21202633717},{"date":"2022-01-28","current":-14.534275,"twenty":-21.562934,"median":-20.260299,"eighty":-18.52558,"marketCap":16545407814},{"date":"2022-02-04","current":-14.146452,"twenty":-21.41835,"median":-20.123216,"eighty":-17.613539,"marketCap":16096026367},{"date":"2022-02-11","current":-13.816944,"twenty":-21.209422,"median":-19.299968,"eighty":-14.985471,"marketCap":15752862353},{"date":"2022-02-18","current":-13.849256,"twenty":-20.857344,"median":-18.911796,"eighty":-14.543623,"marketCap":15867250357},{"date":"2022-02-25","current":-14.199347,"twenty":-20.701287,"median":-17.613539,"eighty":-14.146452,"marketCap":16308461232},{"date":"2022-03-04","current":-14.080132,"twenty":-20.680988,"median":-15.318994,"eighty":-14.146452,"marketCap":16177732084},{"date":"2022-03-11","current":-11.936356,"twenty":-20.490215,"median":-14.985471,"eighty":-13.996814,"marketCap":13693878269},{"date":"2022-03-18","current":-11.726724,"twenty":-20.277602,"median":-14.700549,"eighty":-13.379502,"marketCap":13399737686},{"date":"2022-03-25","current":-12.670051,"twenty":-20.242995,"median":-14.554967,"eighty":-13.072377,"marketCap":14478253158},{"date":"2022-04-01","current":-9.59311,"twenty":-20.003436,"median":-14.538949,"eighty":-12.331764,"marketCap":12697068515},{"date":"2022-04-08","current":-10.156641,"twenty":-19.508494,"median":-14.196743,"eighty":-11.833638,"marketCap":13448761116},{"date":"2022-04-14","current":-9.530673,"twenty":-19.333884,"median":-14.131899,"eighty":-11.51878,"marketCap":12599021653},{"date":"2022-04-22","current":-8.780037,"twenty":-19.299831,"median":-14.060726,"eighty":-10.573986,"marketCap":11389777033},{"date":"2022-04-29","current":-9.576611,"twenty":-19.278065,"median":-13.849256,"eighty":-10.115287,"marketCap":12223175352},{"date":"2022-05-06","current":-7.86231,"twenty":-19.112154,"median":-13.498553,"eighty":-9.579911,"marketCap":9951756403},{"date":"2022-05-13","current":-8.110711,"twenty":-18.577865,"median":-13.379502,"eighty":-9.437455,"marketCap":10082485551},{"date":"2022-05-20","current":-9.061494,"twenty":-18.447152,"median":-13.096379,"eighty":-8.947629,"marketCap":11422459320},{"date":"2022-05-27","current":-8.809867,"twenty":-17.613539,"median":-12.670051,"eighty":-8.780037,"marketCap":11095636450},{"date":"2022-06-02","current":-11.227787,"twenty":-16.802517,"median":-12.331764,"eighty":-8.803901,"marketCap":14216794862},{"date":"2022-06-10","current":-12.109337,"twenty":-15.675042,"median":-12.221978,"eighty":-8.825148,"marketCap":15229945760},{"date":"2022-06-17","current":-11.667379,"twenty":-15.244074,"median":-11.936356,"eighty":-8.923897,"marketCap":14658005737},{"date":"2022-06-24","current":-16.485913,"twenty":-15.494316,"median":-12.221978,"eighty":-9.038721,"marketCap":20794105129},{"date":"2022-06-30","current":-14.957001,"twenty":-15.895364,"median":-12.380422,"eighty":-9.079607,"marketCap":18833167906},{"date":"2022-07-08","current":-15.913959,"twenty":-16.531452,"median":-12.638751,"eighty":-9.104893,"marketCap":20058753670},{"date":"2022-07-15","current":-15.322331,"twenty":-16.45611,"median":-12.887919,"eighty":-9.149933,"marketCap":19134050754},{"date":"2022-07-22","current":-14.807486,"twenty":-16.221667,"median":-13.200862,"eighty":-9.216155,"marketCap":18503257872},{"date":"2022-07-29","current":-14.117198,"twenty":-15.979822,"median":-13.449665,"eighty":-9.360153,"marketCap":17662200696},{"date":"2022-08-05","current":-15.298986,"twenty":-15.838747,"median":-13.498553,"eighty":-9.442,"marketCap":19091997895},{"date":"2022-08-12","current":-15.143556,"twenty":-15.77936,"median":-13.923035,"eighty":-9.496416,"marketCap":18923786460},{"date":"2022-08-19","current":-14.616817,"twenty":-15.77936,"median":-14.080132,"eighty":-9.558236,"marketCap":18082729284},{"date":"2022-08-26","current":-14.756101,"twenty":-15.738632,"median":-14.060726,"eighty":-9.58651,"marketCap":21573116564},{"date":"2022-09-02","current":-14.751536,"twenty":-15.714766,"median":-14.080132,"eighty":-9.724865,"marketCap":21489010846},{"date":"2022-09-09","current":-14.98178,"twenty":-15.703366,"median":-14.105484,"eighty":-9.977712,"marketCap":21741327999},{"date":"2022-09-16","current":-13.542084,"twenty":-15.658514,"median":-14.086951,"eighty":-10.115287,"marketCap":19470473624},{"date":"2022-09-23","current":-12.107338,"twenty":-15.550768,"median":-14.041319,"eighty":-10.199224,"marketCap":17073460672},{"date":"2022-09-30","current":-12.91765,"twenty":-15.461818,"median":-13.978573,"eighty":-10.287783,"marketCap":18250940719},{"date":"2022-10-07","current":-16.281937,"twenty":-15.588998,"median":-14.018764,"eighty":-10.343921,"marketCap":23002913763},{"date":"2022-10-14","current":-15.674276,"twenty":-15.588998,"median":-14.040715,"eighty":-10.440625,"marketCap":21909539434},{"date":"2022-10-21","current":-18.781307,"twenty":-15.710601,"median":-14.070137,"eighty":-10.570074,"marketCap":26072772456},{"date":"2022-10-28","current":-18.085263,"twenty":-15.888888,"median":-14.117198,"eighty":-10.76408,"marketCap":25063503844},{"date":"2022-11-04","current":-18.001131,"twenty":-16.380537,"median":-14.170295,"eighty":-10.773453,"marketCap":25189662421},{"date":"2022-11-11","current":-17.246398,"twenty":-16.644748,"median":-14.199347,"eighty":-10.843556,"marketCap":24348605245},{"date":"2022-11-18","current":-21.310798,"twenty":-17.050284,"median":-14.308051,"eighty":-11.043704,"marketCap":29983688324},{"date":"2022-11-25","current":-18.980602,"twenty":-17.498612,"median":-14.382807,"eighty":-11.22006,"marketCap":26493301044},{"date":"2022-12-02","current":-19.013979,"twenty":-17.995008,"median":-14.534799,"eighty":-11.242055,"marketCap":26997935349},{"date":"2022-12-09","current":-24.062263,"twenty":-18.437795,"median":-14.543856,"eighty":-11.359054,"marketCap":34483344216},{"date":"2022-12-16","current":-24.530301,"twenty":-18.889555,"median":-14.574904,"eighty":-11.602588,"marketCap":35072084239},{"date":"2022-12-23","current":-25.228352,"twenty":-19.041941,"median":-14.612379,"eighty":-11.627361,"marketCap":36081352850},{"date":"2022-12-30","current":-24.983629,"twenty":-19.09779,"median":-14.616563,"eighty":-11.655751,"marketCap":36165458568},{"date":"2023-01-06","current":-26.109825,"twenty":-19.246994,"median":-14.727609,"eighty":-11.666513,"marketCap":38183995790},{"date":"2023-01-13","current":-27.482086,"twenty":-19.35432,"median":-14.788719,"eighty":-11.675194,"marketCap":40959484471},{"date":"2023-01-20","current":-27.207673,"twenty":-19.72973,"median":-14.927803,"eighty":-11.681264,"marketCap":40202533012},{"date":"2023-01-27","current":-29.02317,"twenty":-19.973183,"median":-14.953302,"eighty":-11.681837,"marketCap":42893915976},{"date":"2023-02-03","current":-27.684735,"twenty":-20.135985,"median":-14.979187,"eighty":-11.694899,"marketCap":41127695906},{"date":"2023-02-10","current":-25.345976,"twenty":-20.490215,"median":-14.987339,"eighty":-11.726724,"marketCap":37427044332},{"date":"2023-02-17","current":-24.322978,"twenty":-20.857344,"median":-15.034554,"eighty":-11.784491,"marketCap":35576718544},{"date":"2023-02-24","current":-24.100109,"twenty":-21.41835,"median":-15.060613,"eighty":-11.860367,"marketCap":34819767086},{"date":"2023-03-03","current":-25.36278,"twenty":-22.807081,"median":-15.131721,"eighty":-11.936356,"marketCap":36880357167},{"date":"2023-03-10","current":-22.900092,"twenty":-23.768741,"median":-23.203261,"eighty":-23.03994,"marketCap":33053547016},{"date":"2023-03-17","current":-29.09369,"twenty":-36.802165,"median":-25.36278,"eighty":-15.020812,"marketCap":38688630096},{"date":"2023-03-24","current":-25.324343,"twenty":-36.777216,"median":-25.389232,"eighty":-15.036479,"marketCap":34062815628},{"date":"2023-03-31","current":-25.456261,"twenty":-36.704597,"median":-25.488573,"eighty":-15.049117,"marketCap":33978709910},{"date":"2023-04-06","current":-27.774061,"twenty":-36.623868,"median":-25.540624,"eighty":-15.058257,"marketCap":37048568602},{"date":"2023-04-14","current":-29.730818,"twenty":-36.485136,"median":-25.637411,"eighty":-15.064541,"marketCap":39697898707},{"date":"2023-04-21","current":-26.784111,"twenty":-36.470425,"median":-25.724076,"eighty":-15.129637,"marketCap":35744929980},{"date":"2023-04-28","current":-27.207269,"twenty":-36.436465,"median":-26.010547,"eighty":-15.131721,"marketCap":36039299991},{"date":"2023-05-05","current":-28.335447,"twenty":-36.311562,"median":-26.064869,"eighty":-15.141189,"marketCap":37595255767},{"date":"2023-05-12","current":-27.159579,"twenty":-36.18971,"median":-26.086367,"eighty":-15.143863,"marketCap":35786982838},{"date":"2023-05-19","current":-24.342298,"twenty":-36.161524,"median":-26.085247,"eighty":-15.156,"marketCap":31623749817},{"date":"2023-05-25","current":-24.063272,"twenty":-36.158475,"median":-26.064869,"eighty":-15.180082,"marketCap":31203221229},{"date":"2023-06-02","current":-23.645458,"twenty":-36.149195,"median":-25.984476,"eighty":-15.257042,"marketCap":30488322630},{"date":"2023-06-09","current":-23.222359,"twenty":-36.112659,"median":-25.723039,"eighty":-15.312993,"marketCap":29899582606},{"date":"2023-06-16","current":-24.58122,"twenty":-36.07905,"median":-25.633881,"eighty":-15.343575,"marketCap":31497591241},{"date":"2023-06-23","current":-21.944137,"twenty":-36.043198,"median":-25.488573,"eighty":-15.365065,"marketCap":27965151102},{"date":"2023-06-30","current":-23.543047,"twenty":-35.998611,"median":-25.389232,"eighty":-15.403178,"marketCap":29731371171},{"date":"2023-07-07","current":-23.989446,"twenty":-35.969849,"median":-25.36278,"eighty":-15.455833,"marketCap":30236005477},{"date":"2023-07-14","current":-24.41425,"twenty":-35.912278,"median":-25.312393,"eighty":-15.498928,"marketCap":31203221229},{"date":"2023-07-21","current":-24.59436,"twenty":-35.843663,"median":-25.202538,"eighty":-15.562817,"marketCap":31287326947},{"date":"2023-07-28","current":-28.426335,"twenty":-35.766034,"median":-25.264398,"eighty":-15.623426,"marketCap":36123405709},{"date":"2023-08-04","current":-24.11733,"twenty":-35.704573,"median":-25.300444,"eighty":-15.66297,"marketCap":30698586924},{"date":"2023-08-11","current":-22.294,"twenty":-35.666275,"median":-25.201022,"eighty":-15.683018,"marketCap":28217468254},{"date":"2023-08-18","current":-21.752014,"twenty":-35.64615,"median":-25.173816,"eighty":-15.703366,"marketCap":27334358220},{"date":"2023-08-25","current":-22.10921,"twenty":-35.616771,"median":-25.07893,"eighty":-15.714766,"marketCap":27796939666},{"date":"2023-09-01","current":13.494719,"twenty":-35.601124,"median":-25.008455,"eighty":-15.66297,"marketCap":28974419713},{"date":"2023-09-08","current":13.695117,"twenty":-35.550756,"median":-24.944029,"eighty":-15.455833,"marketCap":29058525430},{"date":"2023-09-15","current":14.848421,"twenty":-35.47221,"median":-24.903626,"eighty":-15.308324,"marketCap":31749908394},{"date":"2023-09-22","current":14.814862,"twenty":-35.438003,"median":-24.827647,"eighty":-15.14371,"marketCap":31539644100},{"date":"2023-09-29","current":14.197918,"twenty":-35.396385,"median":-24.772153,"eighty":-15.059828,"marketCap":30278058336},{"date":"2023-10-06","current":13.889059,"twenty":-35.370319,"median":-24.700469,"eighty":-15.007069,"marketCap":29605212595},{"date":"2023-10-13","current":15.431226,"twenty":-35.30592,"median":-24.632761,"eighty":-14.979706,"marketCap":32843282722},{"date":"2023-10-20","current":14.94053,"twenty":-35.232247,"median":-24.59436,"eighty":-14.914724,"marketCap":31749908394},{"date":"2023-10-27","current":16.35255,"twenty":-35.175876,"median":-24.58122,"eighty":-14.756101,"marketCap":34735661368},{"date":"2023-11-03","current":17.592659,"twenty":-35.129074,"median":-24.511377,"eighty":-14.616308,"marketCap":37469097190},{"date":"2023-11-10","current":18.939266,"twenty":-34.971061,"median":-24.417444,"eighty":-14.569406,"marketCap":40328691589},{"date":"2023-11-17","current":18.319814,"twenty":-34.968612,"median":-24.399566,"eighty":-14.535322,"marketCap":39361475836},{"date":"2023-11-24","current":18.189638,"twenty":-34.895357,"median":-24.342298,"eighty":-14.371526,"marketCap":39403528695},{"date":"2023-12-01","current":18.752497,"twenty":-34.737009,"median":-24.330293,"eighty":-14.199347,"marketCap":40791273036},{"date":"2023-12-08","current":16.771041,"twenty":-34.685609,"median":-24.255162,"eighty":-14.117346,"marketCap":36333670003},{"date":"2023-12-15","current":17.832719,"twenty":-34.615488,"median":-24.15298,"eighty":-14.060142,"marketCap":38856841531},{"date":"2023-12-22","current":16.203086,"twenty":-34.602221,"median":-24.100109,"eighty":-13.960331,"marketCap":35282348533},{"date":"2023-12-29","current":17.826838,"twenty":-34.566441,"median":-24.075355,"eighty":-13.84838,"marketCap":39025052966},{"date":"2024-01-05","current":16.831364,"twenty":-34.502078,"median":-24.025855,"eighty":-13.7643,"marketCap":36585987156},{"date":"2024-01-12","current":17.634525,"twenty":-34.43816,"median":-23.91516,"eighty":-13.515965,"marketCap":38352207225},{"date":"2024-01-19","current":16.051677,"twenty":-34.428025,"median":-23.817977,"eighty":-13.388012,"marketCap":34861819945},{"date":"2024-01-26","current":16.269899,"twenty":-34.417805,"median":-23.667454,"eighty":-13.261099,"marketCap":35198242815},{"date":"2024-02-02","current":15.531605,"twenty":-34.408725,"median":-23.587311,"eighty":-13.092715,"marketCap":33558181322},{"date":"2024-02-09","current":15.823479,"twenty":-34.287198,"median":-23.509747,"eighty":-12.88456,"marketCap":34357185639},{"date":"2024-02-16","current":17.001239,"twenty":-34.118192,"median":-23.29296,"eighty":-12.670051,"marketCap":36922410026},{"date":"2024-02-23","current":17.733723,"twenty":-34.052175,"median":-23.261464,"eighty":-12.429079,"marketCap":38310154366},{"date":"2024-03-01","current":18.170113,"twenty":-33.918444,"median":-23.222586,"eighty":-12.109337,"marketCap":39277370119},{"date":"2024-03-08","current":18.375936,"twenty":-33.875196,"median":-23.212231,"eighty":-11.784491,"marketCap":39739951566},{"date":"2024-03-15","current":20.221708,"twenty":-33.786096,"median":-23.186995,"eighty":-11.680404,"marketCap":43692920293},{"date":"2024-03-22","current":17.596046,"twenty":-33.777607,"median":-23.165857,"eighty":-11.598761,"marketCap":38772735813},{"date":"2024-03-28","current":17.863111,"twenty":-33.671621,"median":-23.133172,"eighty":-11.174522,"marketCap":39235317260},{"date":"2024-04-05","current":17.790526,"twenty":-33.631134,"median":-23.073507,"eighty":-10.781195,"marketCap":39050158637},{"date":"2024-04-12","current":19.515107,"twenty":-33.600204,"median":-23.002422,"eighty":-10.363031,"marketCap":42859930212},{"date":"2024-04-19","current":17.322126,"twenty":-33.582079,"median":-22.887987,"eighty":-9.922708,"marketCap":38011130026},{"date":"2024-04-26","current":19.239838,"twenty":-33.576561,"median":-22.815578,"eighty":-9.479287,"marketCap":42167244471},{"date":"2024-05-03","current":19.371749,"twenty":-33.573712,"median":-22.807081,"eighty":-9.18811,"marketCap":42427001624},{"date":"2024-05-10","current":19.700553,"twenty":-33.522448,"median":-22.755385,"eighty":-8.970402,"marketCap":43249565941},{"date":"2024-05-17","current":19.23578,"twenty":-33.345978,"median":-22.735553,"eighty":-8.780037,"marketCap":42167244471},{"date":"2024-05-24","current":14.667701,"twenty":-33.217784,"median":-22.607363,"eighty":-8.675073,"marketCap":32080008370},{"date":"2024-05-31","current":17.401421,"twenty":-33.106388,"median":-22.460124,"eighty":-8.554056,"marketCap":38097715744},{"date":"2024-06-07","current":16.096502,"twenty":-33.061925,"median":-22.417733,"eighty":-8.291628,"marketCap":35197094204},{"date":"2024-06-14","current":15.794192,"twenty":-33.047794,"median":-22.339227,"eighty":-8.117822,"marketCap":34504408463},{"date":"2024-06-21","current":14.159201,"twenty":-33.01008,"median":-22.315076,"eighty":-7.860137,"marketCap":30867808324},{"date":"2024-06-28","current":14.999486,"twenty":-32.90826,"median":-22.280642,"eighty":13.494356,"marketCap":32686108394},{"date":"2024-07-05","current":15.459781,"twenty":-32.881624,"median":-22.258985,"eighty":13.627238,"marketCap":33681844146},{"date":"2024-07-12","current":15.952998,"twenty":-32.86657,"median":-22.065202,"eighty":13.703744,"marketCap":34807458475},{"date":"2024-07-19","current":15.972541,"twenty":-32.832239,"median":-21.944137,"eighty":13.863497,"marketCap":34850751334},{"date":"2024-07-26","current":16.071567,"twenty":-32.814226,"median":-21.7966,"eighty":14.148348,"marketCap":35197094204},{"date":"2024-08-02","current":16.61499,"twenty":-32.811697,"median":-21.752014,"eighty":14.411832,"marketCap":36366001392},{"date":"2024-08-09","current":17.212345,"twenty":-32.808943,"median":-21.597174,"eighty":14.509977,"marketCap":37924544308},{"date":"2024-08-16","current":17.657405,"twenty":-32.804956,"median":-21.439655,"eighty":14.640353,"marketCap":38920280061},{"date":"2024-08-23","current":17.9547,"twenty":-32.79969,"median":-21.418042,"eighty":14.703604,"marketCap":39742844378},{"date":"2024-08-30","current":-52.624506,"twenty":-32.804956,"median":-21.417734,"eighty":14.818346,"marketCap":42513587341},{"date":"2024-09-06","current":-51.635037,"twenty":-32.832239,"median":-21.438942,"eighty":14.78042,"marketCap":41734315883},{"date":"2024-09-13","current":-66.216902,"twenty":-33.018625,"median":-21.520592,"eighty":14.703604,"marketCap":53380094900},{"date":"2024-09-20","current":-69.932725,"twenty":-33.173226,"median":-21.714319,"eighty":14.662246,"marketCap":56713645028},{"date":"2024-09-27","current":-71.531113,"twenty":-33.576561,"median":-21.771586,"eighty":14.652247,"marketCap":58358773662},{"date":"2024-10-04","current":-79.320454,"twenty":-33.638129,"median":-21.813706,"eighty":14.649255,"marketCap":64419773894},{"date":"2024-10-10","current":-69.213885,"twenty":-33.875196,"median":-21.986037,"eighty":14.648182,"marketCap":55847787852},{"date":"2024-10-18","current":-74.646599,"twenty":-34.399868,"median":-22.081407,"eighty":14.635134,"marketCap":59917316579},{"date":"2024-10-25","current":-77.719883,"twenty":-34.441314,"median":-22.265924,"eighty":14.560741,"marketCap":62380223732},{"date":"2024-11-01","current":-76.214752,"twenty":-34.685609,"median":-22.294,"eighty":14.556702,"marketCap":61213399403},{"date":"2024-11-08","current":-76.2814,"twenty":-34.971061,"median":-22.333531,"eighty":14.515997,"marketCap":60989010109},{"date":"2024-11-15","current":-78.00551,"twenty":-35.320815,"median":-22.40582,"eighty":14.505964,"marketCap":61707055850},{"date":"2024-11-22","current":-81.958791,"twenty":-35.480573,"median":-22.437728,"eighty":14.479729,"marketCap":64803628107},{"date":"2024-11-29","current":-83.036127,"twenty":-35.659842,"median":-22.470599,"eighty":14.463817,"marketCap":65611429565},{"date":"2024-12-06","current":-74.237179,"twenty":-35.878177,"median":-22.720101,"eighty":14.435399,"marketCap":58520727875},{"date":"2024-12-13","current":-72.615659,"twenty":-36.070462,"median":-22.745547,"eighty":14.396121,"marketCap":57129514252},{"date":"2024-12-20","current":-69.730236,"twenty":-36.160141,"median":-22.79318,"eighty":14.28027,"marketCap":54616354159},{"date":"2024-12-27","current":-68.121477,"twenty":-36.342788,"median":-22.81524,"eighty":14.230859,"marketCap":53314896254},{"date":"2025-01-03","current":-66.794572,"twenty":-36.589185,"median":-22.863096,"eighty":14.182431,"marketCap":52327583360},{"date":"2025-01-10","current":-64.575988,"twenty":-36.921451,"median":-22.916115,"eighty":14.151966,"marketCap":50397835432},{"date":"2025-01-17","current":-67.97132,"twenty":-37.388459,"median":-23.037405,"eighty":14.124517,"marketCap":53090506960},{"date":"2025-01-24","current":-71.487894,"twenty":-37.630978,"median":-23.112092,"eighty":14.06824,"marketCap":56187079217},{"date":"2025-01-28","current":-69.159217,"twenty":-37.749998,"median":-23.133265,"eighty":14.036856,"marketCap":54616354159},{"date":"2025-02-07","current":-74.204707,"twenty":-38.720974,"median":-23.179575,"eighty":13.91548,"marketCap":58296338581},{"date":"2025-02-14","current":-68.942526,"twenty":-39.742666,"median":-23.199597,"eighty":13.854976,"marketCap":54032941995},{"date":"2025-02-21","current":-78.532535,"twenty":-40.936164,"median":-23.213534,"eighty":13.833941,"marketCap":61886567285},{"date":"2025-02-28","current":-83.363188,"twenty":-41.78603,"median":-23.229233,"eighty":13.752998,"marketCap":65476795989},{"date":"2025-03-07","current":-82.972913,"twenty":-43.765472,"median":-23.273351,"eighty":13.720056,"marketCap":65431918130},{"date":"2025-03-14","current":-81.918752,"twenty":-44.36559,"median":-23.404228,"eighty":13.69943,"marketCap":64624116672},{"date":"2025-03-21","current":-77.113549,"twenty":-46.703645,"median":-23.571971,"eighty":13.681934,"marketCap":60809498674},{"date":"2025-03-28","current":-85.082441,"twenty":-50.561624,"median":-23.656456,"eighty":13.67268,"marketCap":66957765329},{"date":"2025-04-03","current":-139.968555,"twenty":-51.651807,"median":-23.75284,"eighty":13.662257,"marketCap":77100161418},{"date":"2025-04-11","current":-135.149196,"twenty":-52.531592,"median":-23.854164,"eighty":13.627238,"marketCap":73779199867},{"date":"2025-04-17","current":-136.201828,"twenty":-53.202931,"median":-23.974596,"eighty":13.597708,"marketCap":74452367749},{"date":"2025-04-25","current":-162.080631,"twenty":-54.264543,"median":-23.982021,"eighty":13.592632,"marketCap":88770184906},{"date":"2025-05-02","current":-143.58439,"twenty":-55.295104,"median":-23.989446,"eighty":13.587555,"marketCap":78807100452},{"date":"2025-05-09","current":-136.980788,"twenty":-56.345373,"median":-23.982021,"eighty":13.592632,"marketCap":75710466095},{"date":"2025-05-16","current":-134.501562,"twenty":-57.376977,"median":-23.982021,"eighty":13.592632,"marketCap":74947527196},{"date":"2025-05-23","current":-133.538341,"twenty":-57.747713,"median":-23.982021,"eighty":13.592632,"marketCap":74633375884},{"date":"2025-05-30","current":-133.993142,"twenty":-58.91872,"median":-23.982021,"eighty":13.592632,"marketCap":75216799748},{"date":"2025-06-06","current":-131.180073,"twenty":-59.359698,"median":-23.982021,"eighty":13.592632,"marketCap":73825558226},{"date":"2025-06-13","current":-152.810216,"twenty":-59.540166,"median":-23.982021,"eighty":13.592632,"marketCap":86032580619}],"updateTime":1749877718927}}}